Sorrento Therapeutics Inc (SRNE)

[dia76ca]

OVYDSO (oral anti-viral) phase 3 trial began dosing in China Feb.2 2003! Summary...
"40 trial centers with an avg. 30 patients per center. Trial is double blinded, 50/50 Mpro v. placebo, 600 patients get Mpro and 600 get a placebo. Dosing 2x day for 5 days + 24 days follow up (+29Days from day 1). Trial could be completed rapidly ..." Pfizer drug(with liver and drug/drug interaction problems) with very high cost(subsidized by Western governments) earned $20+ Billion last year!